Your browser doesn't support javascript.
loading
dUTPase inhibition augments replication defects of 5-Fluorouracil.
Hagenkort, Anna; Paulin, Cynthia B J; Desroses, Matthieu; Sarno, Antonio; Wiita, Elisée; Mortusewicz, Oliver; Koolmeister, Tobias; Loseva, Olga; Jemth, Ann-Sofie; Almlöf, Ingrid; Homan, Evert; Lundbäck, Thomas; Gustavsson, Anna-Lena; Scobie, Martin; Helleday, Thomas.
Afiliación
  • Hagenkort A; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Paulin CBJ; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Desroses M; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Sarno A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Wiita E; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Mortusewicz O; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Koolmeister T; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Loseva O; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Jemth AS; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Almlöf I; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Homan E; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Lundbäck T; Chemical Biology Consortium Sweden, Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Gustavsson AL; Chemical Biology Consortium Sweden, Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Scobie M; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Helleday T; Division of Translational Medicine and Chemical Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Oncotarget ; 8(14): 23713-23726, 2017 Apr 04.
Article en En | MEDLINE | ID: mdl-28423595
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirofosfatasas / Protocolos de Quimioterapia Combinada Antineoplásica / Replicación del ADN / Inhibidores Enzimáticos / Fluorouracilo / Neoplasias Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirofosfatasas / Protocolos de Quimioterapia Combinada Antineoplásica / Replicación del ADN / Inhibidores Enzimáticos / Fluorouracilo / Neoplasias Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Suecia